Citation Impact
Citing Papers
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
2012 StandoutScience
Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and α-synuclein
2005 StandoutNobel
The 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist
2008 StandoutScience
Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease
2002 StandoutScience
Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional Coactivators
2006 Standout
The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives
1999 StandoutNature
Toxin-induced models of Parkinson’s disease
2005
Apoptosis in neurodegenerative disorders
2000
Chronic theophylline treatment increases adenosine A1, but not A2, receptor binding in the rat brain: An autoradiographic study
1991
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
2009 Standout
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
1996 StandoutNature
An update on the mechanisms of the psychostimulant effects of caffeine
2007
Parkinson's Disease–Associated Kinase PINK1 Regulates Miro Protein Level and Axonal Transport of Mitochondria
2012
Adenosine A2B‐receptor‐mediated cyclic AMP accumulation in primary rat astrocytes
1994
Modulation of striatal adenosine A1 and A2 receptors induces rotational behaviour in response to dopaminergic stimulation in intact rats
1994
Vertebrate Hedgehog signalling modulated by induction of a Hedgehog-binding protein
1999 StandoutNature
Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1
2000 StandoutNobel
Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis
1997
Chronic theophylline treatment in vivo increases high affinity adenosine A1 receptor binding and sensitivity to exogenous adenosine in the in vitro hippocampal slice
1991
The Ubiquitin Proteasome System in Neurodegenerative Diseases
2003 StandoutNobel
Inhibition by KF17837 of adenosine A2A receptor‐mediated modulation of striatal GABA and ACh release
1994
Solving the Distal Reward Problem through Linkage of STDP and Dopamine Signaling
2007
Adenosine receptor‐induced cAMP changes in D384 astrocytoma cells and the effect of bradykinin thereon
1992
Characterization of the depression of rat cerebral cortical neurons by selective adenosine agonists
1991
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
The binding of the adenosine A2 receptor selective agonist [3H]CGS 21680 to rat cortex differs from its binding to rat striatum
1993
Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease
2009
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
2015 Standout
Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease
2003
Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and Fos immunoreactivity in rat striatal neurons
1995
Nerve Growth Factor Gene Therapy in Alzheimer Disease
2007
Defects in enteric innervation and kidney development in mice lacking GDNF
1996 StandoutNature
Agonist activity of 2- and 5′-substituted adenosine analogs and their N6-cycloalkyl derivatives at A1− and A2−adenosine receptors coupled to adenylate cyclase
1992
Expression of GDNF transgene in astrocytes improves cognitive deficits in aged rats
2007
Characterization of the adenosine receptor in microvascular coronary endothelial cells
1994
Characterization of P1‐purinoceptors on rat duodenum and urinary bladder
1992
Adenosine A1 receptor-mediated inhibition of cyclic AMP accumulation in type-2 but not type-1 rat astrocytes
1996
Adenosine A2aReceptor‐Mediated Modulation of Striatal [3H]GABA and [3H]Acetylcholine Release
1994
Chronic oral nicotine treatment protects against striatal degeneration in MPTP‐treated primates
2006
Cell Death
2004 Standout
The dopamine hypothesis of the reinforcing properties of cocaine
1991
A Common Mechanism Mediates Long-Term Changes in Synaptic Transmission after Chronic Cocaine and Morphine
1996
Functional characterization of the A2b adenosine receptor in NIH 3T3 fibroblasts
1994
Possible role for G-proteins in behavioral sensitization to cocaine
1991
C. elegans Locomotory Rate Is Modulated by the Environment through a Dopaminergic Pathway and by Experience through a Serotonergic Pathway
2000 StandoutNobel
The role of dopamine in drug abuse viewed from the perspective of its role in motivation
1995
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Catecholamine release and uptake in the mouse prefrontal cortex
2001
Brain catecholamine metabolism in catechol‐O‐methyltransferase (COMT)‐deficient mice
2002
Essential Roles in Synaptic Plasticity for Synaptogyrin I and Synaptophysin I
1999 StandoutNobel
Neuroinflammation and Cognitive Aging
2010
Molecular mechanisms of drug addiction
2004
Dynamic Observation of Dopamine Autoreceptor Effects in Rat Striatal Slices
1992
Parkinson's disease
2015 Standout
Neurotrophic Mechanisms in Drug Addiction
2004
Adenosine receptor‐mediated modulation of acetylcholine release from rat striatal synaptosomes
1993
Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters
2005 StandoutNature
Electrophysiological Correlates of Psychomotor Stimulant‐induced Sensitizationa
1992
α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration
2005 StandoutNobel
Adenosine A2 receptor-mediated excitatory actions on the nervous system
1996
Parkinson's Disease: Gene Therapies
2012
Changes in basal and cocaine-evoked extracellular dopamine uptake and release in the rat nucleus accumbens during early abstinence from cocaine: quantitative determination under transient conditions
2002
Five-Year Follow-up of Bilateral Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
2003 Standout
Adenosine A2a Receptor Modulation of Electrically Evoked Endogenous GABA Release from Slices of Rat Globus Pallidus
1993
Autophagy in Human Health and Disease
2013 Standout
Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders
2004
Low-Level Lead Exposure Selectively Enhances Dopamine Overflow in Nucleus Accumbens: AnIn VivoElectrochemistry Time Course Assessment
1998
Novel pharmacological targets for the treatment of Parkinson's disease
2006
Adenosine receptor‐mediated relaxation of guinea‐pig precontracted, isolated trachea
1995
Neurodegeneration and Inflammation in Parkinson's disease
2011
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
2005 StandoutNobel
Neurotoxic in vivo models of Parkinson’s disease
2010
Adenosine inhibits the synaptic potentials in rat septal nucleus neurons mediated through pre- and postsynaptic A1-adenosine receptors
1992
The relevance of iron in the pathogenesis of Parkinson’s disease
2010
Neurotransmitter Transporters: Recent Progress
1993
Ret rescues mitochondrial morphology and muscle degeneration of Drosophila Pink1 mutants
2014
Alzheimer's Disease
2010 Standout
Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity
1991 Standout
Major Depressive Disorder
2008 Standout
Evidence for adenosine A2b receptors in the rat pineal gland
1992
Parkinson's Disease
1998 Standout
Basic mechanisms of neurodegeneration: a critical update
2010
Alpha-synuclein-induced neurodegeneration is exacerbated in PINK1 knockout mice
2014
Characterization of P1‐purinoceptors on rat isolated duodenum longitudinal muscle and muscularis mucosae
1996
Developmental cell death in dopaminergic neurons of the substantia nigra of mice
2000
Molecular cloning and expression of an adenosine A2b receptor from human brain
1992
Systematic Mutagenesis of α-Synuclein Reveals Distinct Sequence Requirements for Physiological and Pathological Activities
2012 StandoutNobel
Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts
2011
Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys
1995
Dual Signalling by the Adenosine A2a Receptor Involves Activation of Both N‐ and P‐Type Calcium Channels by Different G Proteins and Protein Kinases in the Same Striatal Nerve Terminals
1996
Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice
2003 StandoutNobel
The PI3K Pathway in Human Disease
2017 Standout
Contribution of P1 (A2b subtype) and P2‐purinoceptors to the control of vascular tone in the rat isolated mesenteric arterial bed
1995
Solvent exposures and parkinson disease risk in twins
2011
Differential effects of adenosine receptor subtypes on release and reuptake of hippocampal serotonin
1999
Molecular characterization of a human brain adenosine A2 receptor
1992
Are synucleinopathies prion-like disorders?
2010
Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease
2013
Renal agenesis and the absence of enteric neurons in mice lacking GDNF
1996 StandoutNature
Purinoceptor modulation of noradrenaline release in rat tail artery: tonic modulation mediated by inhibitory P2Y‐ and facilitatory A2A‐purinoceptors
1996
Continuous cocaine administration produces persisting changes in brain neurochemistry and behavior
1991
Molecular Mechanisms of Drug Reinforcement and Addiction
1995
Neurodegeneration and neuroprotection in Parkinson disease
2004
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
The Adenosine Receptors Present on the Plasma Membrane of Chromaffin Cells Are of the A2b Subtype
1992
Parkinson's Disease
2003 Standout
Characterization of the human brain putative A2B adenosine receptor expressed in Chinese hamster ovary (CHO.A2B4) cells
1996
Neurodegeneration Prevented by Lentiviral Vector Delivery of GDNF in Primate Models of Parkinson's Disease
2000 Science
A Neural Substrate of Prediction and Reward
1997 StandoutScience
A catechol- O -methyltransferase that is essential for auditory function in mice and humans
2008 StandoutNobel
D2 dopamine receptor activation of potassium channels in identified rat lactotrophs: whole-cell and single-channel recording
1991
Adenosine A2aand A2bReceptors in Cultured Fetal Chick Heart Cells
1995
Receptors for Purines and Pyrimidines
1998 Standout
Solving the distal reward problem through linkage of STDP and dopamine signaling
2007
Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
1991
Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat Stress
2006 StandoutScience
Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinsons Disease
2007
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Presynaptic inhibition of excitatory synaptic transmission by adenosine in rat hippocampus: analysis of unitary EPSP variance measured by whole- cell recording
1992
Modulation of Both the Early and the Late Phase of Mossy Fiber LTP by the Activation of β-Adrenergic Receptors
1996 StandoutNobel
MUL1 acts in parallel to the PINK1/parkin pathway in regulating mitofusin and compensates for loss of PINK1/parkin
2014
Trophic Factor Gene Therapy for Parkinson's Disease
2013
Molecular mechanisms of drug addiction [published erratum appears in J Neurosci 1992 Aug;12(8):following table of contents]
1992
Neurotransmitter Transporters in the Central Nervous System
1999
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use
1999 Standout
Enhanced Rewarding Properties of Morphine, but not Cocaine, in βarrestin-2 Knock-Out Mice
2003 StandoutNobel
Tuberculosis: Commentary on a Reemergent Killer
1992 StandoutScience
MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine
1994
Adenosine-dopamine interactions in the brain
1992
Drug Abuse: Hedonic Homeostatic Dysregulation
1997 StandoutScience
Changes in Extracellular Dopamine Induced by Morphine and Cocaine: Crucial Control by D2 Receptors
2002
Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins
1997
Neurodynamics of mental exploration
2009 StandoutNobel
Role of ATP-sensitive K+ channels in antinociception induced by R-PIA, an adenosine A1 receptor agonist
1994
Protection by Synergistic Effects of Adenovirus-Mediated X-Chromosome-Linked Inhibitor of Apoptosis and Glial Cell Line-Derived Neurotrophic Factor Gene Transfer in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease
2000
Adenosine A2A receptor stimulation increases release of acetylcholine from rat hippocampus but not striatum, and does not affect catecholamine release
1996
A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase.
1992
Facilitatory and inhibitory modulation by endogenous adenosine of noradrenaline release in the epididymal portion of rat vas deferens
1993
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
2004 StandoutScience
Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine.
1992
Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration
2001
Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons
1993
Comparison of the actions of adenosine at pre‐ and postsynaptic receptors in the rat hippocampus in vitro.
1992
Activation of metabotropic glutamate receptors increases cAMP accumulation in hippocampus by potentiating responses to endogenous adenosine
1993
Dopamine-modulated potassium channels on rat striatal neurons: specific activation and cellular expression
1995
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
2003 StandoutScience
The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain
1993
Dopamine Receptors: From Structure to Function
1998 Standout
Adenosine A2receptor‐mediated excitation of a subset of AH/Type 2 neurons and elevation of cAMP levels in myenteric ganglia of guinea‐pig ileum
1994
Both Protein Kinase A and Mitogen-Activated Protein Kinase Are Required in the Amygdala for the Macromolecular Synthesis-Dependent Late Phase of Long-Term Potentiation
2000 StandoutNobel
Works of Wayne A. Cass being referenced
Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats
2009
Persistence of neurochemical changes in dopamine systems after repeated cocaine administration.
1990
Differences in Dopamine Clearance and Diffusion in Rat Striatum and Nucleus Accumbens Following Systemic Cocaine Administration
1992
Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys
2002
Clearance of Exogenous Dopamine in Rat Dorsal Striatum and Nucleus Accumbens: Role of Metabolism and Effects of Locally Applied Uptake Inhibitors
1993
Arachidonic acid metabolites do not mediate modulation of neurotransmitter release by adenosine in rat hippocampus or striatum
1990
Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake
1994
Increased Mitochondrial Calcium Sensitivity and Abnormal Expression of Innate Immunity Genes Precede Dopaminergic Defects in Pink1-Deficient Mice
2011
Increased dopamine clearance in the non-lesioned striatum of rhesus monkeys with unilateral 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) striatal lesions
1995
Neuroprotective effects of GDNF against 6-OHDA in young and aged rats
2001
In Vivo Electrochemical Studies of Dopamine Overflow and Clearance in the Striatum of Normal and MPTP‐Treated Rhesus Monkeys
1996
Reduced Clearance of Exogenous Dopamine in Rat Nucleus Accumbens, but Not in Dorsal Striatum, Following Cocaine Challenge in Rats Withdrawn from Repeated Cocaine Administration
1993
Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system
2006
In Vivo Assessment of Dopamine Uptake in Rat Medial Prefrontal Cortex: Comparison with Dorsal Striatum and Nucleus Accumbens
1995
Iron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys
2006
GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's disease
2006
Striatal Neuroinflammation Promotes Parkinsonism in Rats
2009
Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity
2007
Age-related changes in potassium-evoked overflow of dopamine in the striatum of the rhesus monkey
1995
Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys
1995
Functional recovery in parkinsonian monkeys treated with GDNF
1996 Nature
Potassium Channel Blockers Inhibit D2 Dopamine, but Not A1Adenosine, Receptor‐Mediated Inhibition of Striatal Dopamine Release
1991
Intrastriatal lipopolysaccharide injection induces parkinsonism in C57/B6 mice
2009
Inhibitors of arachidonic acid metabolism: effects on rat striatal dopamine release and uptake.
1991
Decreases in Evoked Overflow of Dopamine in Rat Striatum after Neurotoxic Doses of Methamphetamine
1997
GDNF Protection against 6-OHDA: Time Dependence and Requirement for Protein Synthesis
1997
Inhibition of striatal dopamine release by the selective D‐2 dopamine receptor agonist N‐0437 is blocked by quinine
1990
Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum.
1990
Glial Cell Line-Derived Neurotrophic Factor Increases Stimulus-Evoked Dopamine Release and Motor Speed in Aged Rhesus Monkeys
2003